In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

In a turbulent market environment, Moderna Inc (BMV:MRNA). shares have touched a 52-week low, sinking to $30.7, with concerning financial metrics showing negative EBITDA of $2.36 billion and gross ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...

Legislation that would ban mRNA vaccinations statewide — including the Covid-19 vaccine — drew equal parts support and opposition during a House Judiciary Committee hearing on Friday. House Bill 371, ...

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz with ...

This is the year to be optimistic about Alzheimer’s disease says one of Australia’s leading dementia researchers.

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

The claim that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic is false. His remarks at Davos 2023 ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...